Declared technologies base

TRANSFER OF INNOVATIONAL TECHNOLOGIES

TEST SYSTEM STMEC ("ECT-MEK") FOR RAPID ANALYSIS OF THE PRESENCE IN CLINICAL MATERIALS STAPHYLOCOCCI, AND THEIR RESISTANCE TO BETA-LACTAM ANTIBIOTICS


Purpose of the development: Test system for rapid analysis of the presence in clinical samples of staphylococci (Staphylocociis spp:. S.aureus S.epidermidis S.haemolyticus etc...), And their resistance to beta-lactam antibiotics, which are antibiotics of first choice in the treatment of staphylococcal infections.

Recommended application field: Medical diagnostics; clinic, health care institutions.

Advantages over analogues: Rapid diagnosis for three-four hours (the traditional test takes at least three days). StMec based on PCR, therefore, does not require a lot of time, is an economic (cheaper than traditional bacteriological methods), high sensitivity (sensitivity up to 90-95% as opposed to the traditional method, whose sensitivity varies between 50-60%) and highly specific (specificity - ability to identify resistance to beta-lactam antibiotics is 90-95%, the traditional diagnostic method is 40%).

The development stage readiness: Tested experimental exploitation order

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Technological document's sale
Combinated reduction to industrial level

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua

or fill out the form:
Organization name :
Address :
Settlement account :
Bank :
MFO :
OKPO code :

Scientific organization tutor's data :
Surname :
Name :
Patronymic :
Scientific degree :
Phone :
Fax :
E-mail :
Cooperation proposals (joint patent, joint enterprise, assembly sale and so on :
country: